Adding coronary calcium to the assessment of conventional cardiovascular risk factors leads to substantial improvement in cardiovascular risk classification of asymptomatic men and women, according to a study presented at the RSNA on Wednesday afternoon.
Adding coronary calcium to the assessment of conventional cardiovascular risk factors leads to substantial improvement in cardiovascular risk classification of asymptomatic men and women, according to a study presented at the RSNA on Wednesday afternoon.
Strong associations were found between the extent of coronary calcium and the risk of coronary events, with hazard ratios up to 9.6 in men and up to 21.6 in women, said presenter of the study Dr. Rozemarijn Vliegenthart Proenca, a radiology resident at the University Medical Center Groningen in the Netherlands.
More than 2000 asymptomatic patients were assessed by electron-beam tomography to determine amounts of coronary calcium in this prospective population-based study. When coronary calcium was added to the Framingham risk model, reclassification was most substantial in subjects initially classified as intermediate risk.
In men, 65% of those originally classified as at an intermediate risk were reclassified when coronary calcium was added to the risk model. More than a third (38%) moved to the low-risk category, and 27% moved to the high-risk category.
In women, 66% of those originally classified as at an intermediate risk were reclassified when coronary calcium was added to the risk model. Nearly half (45%) moved to the low-risk category, and 21% moved to the high-risk category.
“The reclassification was based on the actual events,” Proenca said. “So the observed risks in the different categories were repopulated based on our risk model, our prediction model, and based on the actual events occurring in the risk categories.”
Other studies have just shown that a high calcium score can affect risk stratification in a population, but were not based on actual events, she said.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the recent RSNA conference.
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.